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ABSTRACT: Proteomics and other protein-based analysis
methods such as Western blotting all face the challenge of
discriminating changes in the levels of proteins of interest from
inadvertent changes in the amount loaded for analysis. Mass-
spectrometry-based proteomics can now estimate the relative
and absolute amounts of thousands of proteins across diverse
biological systems. We reasoned that this new technology
could prove useful for selection of very stably expressed
proteins that could serve as better loading controls than those
traditionally employed. Large-scale proteomic analyses of SDS
lysates of cultured cells and tissues revealed deglycase DJ-1 as
the protein with the lowest variability in abundance among different cell types in human, mouse, and amphibian cells. The
protein constitutes 0.069 ± 0.017% of total cellular protein and occurs at a specific concentration of 34.6 ± 8.7 pmol/mg of total
protein. Since DJ-1 is ubiquitous and therefore easily detectable with several peptides, it can be helpful in normalization of
proteomic data sets. In addition, DJ-1 appears to be an advantageous loading control for Western blot that is superior to those
used commonly used, allowing comparisons between tissues and cells originating from evolutionarily distant vertebrate species.
Notably, this is not possible by the detection and quantitation of housekeeping proteins, which are often used in the Western blot
technique. The approach introduced here can be applied to select the most appropriate loading controls for MS-based
proteomics or Western blotting in any biological system.
KEYWORDS: DJ-1, PARK7, “Total Protein Approach”, quantitative proteomics, proteomic data normalization, Xenopus,
Western blot, loading control
■ INTRODUCTION
Western blotting (WB) is one of the most widely used
techniques in the life sciences. Employing specific antibodies,
the method allows the identification and relative quantification
of proteins separated by polyacrylamide gel electrophoresis
proteins.1 Ubiquitously expressed proteins, such as β-actin, β-
tubulin, and glyceraldehyde phosphate dehydrogenase
(GAPDH), whose levels are thought to remain unchanged,
serve as loading controls in WB. However, there are many
pitfalls to the technique, which make it semiquantitative at
best.2 Several studies have found that normalization approaches
using integration of total protein blotted appear to be more
accurate.3−5 In particular, the use of sensitive fluorescent labels
allows precise normalization and protein quantitation at a
higher dynamic range compared with standard “enhanced
chemiluminiscence”-based detection.5 Nevertheless, these
methods are not commonly employed because of the
requirement of specific scanning equipment. In any case, the
WB technique remains challenging because of the variability of
antibodies,6 which mainly reflects their specificity and affinity to
antigens. In addition, quantitation with antibodies is usually
limited to 1 order of magnitude of antigen concentration.
Mass spectrometry (MS)-based proteomics has become
increasingly powerful and now allows the identification and
quantification of thousands of proteins in a streamlined and
robust manner. In particular, we have recently demonstrated
that label-free proteomics using the “total protein approach”
allows the determination of concentrations of thousands of
proteins.7,8 We hypothesized that comparing quantitative
proteomic data across diverse cell types and tissues could
pinpoint ubiquitously expressed proteins, which could serve as
more accurate normalization controls. We report the
identification of deglycase DJ-1, a protein that is ubiquitously
expressed and occurs with the lowest titer variability in
proteomes across tissues and cells of vertebrate organisms.
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■ EXPERIMENTAL PROCEDURES
Tissue Isolation and Lysis
Mouse (10-week-old female C57BL/6 mice were bred on a 12
h/12 h light/dark cycle and had free access to standard chow
diet) and Xenopus laevis organs and cultured human cells were
lysed in a buffer containing 0.1 M Tris-HCl (pH 7.4), 2% SDS,
and 0.05 M DTT as described previously.9 The animals were
bred at the Institute’s Animal Facility. Whole organs were
homogenized with Ultra Turrax T8 homogenizer (IKA
Labotechnik). For muscle lysate, the entire gastrocnemius
was used. The cells were directly lysed in the buffer. Total
protein content in the lysates was determined by means of a
tryptophan fluorescence (WF) assay.10
Protein Digestion
Protein lysates were processed using the MED-FASP
protocol11 with modifications described recently.12 Briefly,
aliquots containing 50 μg of total protein were mixed with 200
μL of 8 M urea in 0.1 M Tris/HCl (pH 8.5) (UA) in the
Microcon 30K ultrafiltration unit and then centrifuged at
10000g at 18 °C for 15 min. The eluates were discarded, 100
μL of UA was pipetted into the filtration unit, and the units
were centrifuged again. Then 50 μL of 0.05 M iodoacetamide in
UA was added to the filters, and the samples were incubated in
darkness for 20 min. The filters were washed twice with 100 μL
of UA followed by two washes with 100 μL of 0.05 M Tris/HCl
(pH 8.5) (digestion buffer, DB) and were digested in 40 μL of
the buffer used for washing at 37 °C for 18 h using
endoproteinase LysC (MED FASP) at an enzyme to protein
ratio of 1:50. The released peptides were collected by
centrifugation at 10000g for 10 min followed by two washes
with 100 μL of DB. The material remaining on the filter was
digested with trypsin using the above conditions, except that
the cleavage reaction was performed for only 2 h. The peptide
eluates containing 10 μg of total peptide were concentrated to a
volume of 4−5 μL and were stored frozen at −20 C until mass
spectrometric analysis. Peptides were quantified by the WF
assay.10
LC−MS/MS Analysis
Analysis of the peptide mixtures was performed in an LTQ
Orbitrap instrument (Thermo Fisher Scientific) as described
previously.9,13 Briefly, aliquots containing 6−8 μg of peptides
were injected and separated on a reversed-phase column (20
cm × 75 μm inner diameter) packed with 1.8 μm C18 particles
(Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) using a
4 h acetonitrile gradient in 0.1% formic acid at a flow rate of
250 nL/min. The LC was coupled to the mass spectrometer via
a nanoelectrospray source (Thermo Fisher Scientific). The
Figure 1. DJ-1 protein is a ubiquitous protein with constant expression in vertebrate cells. (A) Protein abundance vs variation of protein
concentration across mouse tissues. For this graph, 2866 proteins identified by LC−MS/MS on an Orbitrap instrument in all of the analyzed tissues
were considered. (B, C) Western blot analysis of whole-cell lysates of selected mouse organs cultured using antibodies against β-actin, β-tubulin,
GADPH, and DJ-1 (PARK7) protein. (D, E) Abundances of β-actin, β-tubulin, GADPH, and DJ-1 (PARK7) protein in mouse organs and human
cell lines (current study). (F) Abundance of DJ-1 protein in native human cells (meta-analysis; for references, see Table S1). (G). Abundance of DJ-
1 (PARK7) protein in the nonmammalian vertebrate Xenopus laevis (current study).
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LTQ Orbitrap instrument was operated in data-dependent
mode with survey scans acquired at a resolution of 60 000 at m/
z 400. For collision-induced dissociation (CID) fragmentation,
up to the 10 most abundant precursor ions from the survey
scan with charge ≥ +2 within the m/z 300−1700 range were
selected. The normalized collision energy was 35. The dynamic
exclusion parameters were 90 s and 5 ppm. The MS/MS
spectra were acquired in the linear ion trap.
Data Analysis
The MS data from mouse and human material were analyzed
using the MaxQuant software14 (version 1.5.3.14). Proteins
were identified by searching MS and MS/MS data for peptides
(54 658 peptides in mouse tissues, 49 726 in human cell lines,
and 25 502 in X. laevis) against a decoy version of UniProtKB
(May 2013). Carbamidomethylation of cysteines was set as a
fixed modification, and N-terminal acetylation and oxidation of
methionine were set as variable modifications. Up to two
missed cleavages were allowed. The initial allowed mass
deviation of the precursor ion was up to 6 ppm, and for the
fragment masses it was 0.5 Da. The “match between runs”
option enabled transfer of identifications across samples within
a time window of 2 min of the aligned retention times. The
maximum false peptide discovery rate was specified as 0.01.
Protein titers were calculated on the basis of the raw spectral
protein intensity (without normalization) of the MaxQuant
software output using the total protein approach (TPA)8
according to the following relationships:
= ×i iPA( ) MS signal( )
total MS signal
100%








total MS signal MW( )
where c(i) is the specific concentration of protein i (in mol/g of
total protein) and MW(i) is its molar mass (in g/mol).
Western Blot Analysis
Mouse organ and cell lysates were electrophoresed, transferred
to nitrocellulose, and probed as described previously.15 Briefly,
aliquots of whole-tissue lysates containing 10 μg of total protein
were separated on SDS gels and blotted onto nitrocellulose.
The completeness of protein transfer was checked by
Coomassie staining of the gel after blotting. After protein
fixation with 0.5% glutaraldehyde, the blots were stained with
Poceau S to test the quality of the protein transfer.15 The
fixation enabled reuse of the same blot several times, thus
saving labor and increasing the comparability of the blots
generated with various antibodies. Antibodies against DJ-1
(PARK 7) were purchased from Pierce/Thermo-Fisher (PAS-
13404, Darmstadt, Germany), ABCAM (ab18257, Cambridge,
U.K.), Biozol (LS-C93055, Eching, Germany), and Sigma-
Aldrich (SAB4500249, Taufkirchen, Germany). Antibodies
against β-actin, β-tubulin, and GAPDH were obtained from
Cell Signaling Technology (Leiden, The Netherlands) with
catalog numbers 4967L, 2125S, and 2118, respectively. The
blots were stripped with a solution containing 2% SDS and 15
mM 2-mercaptoethanol in water at 55 °C for 1 h. Following
several washes with excess water, the blots were reused. Primary
antibody binding was visualized using secondary antibodies and
an enhanced chemiluminescence (ECL) detection system and
scanned using an ImageQuant LAS 4000 instrument (GE
Healthcare).
■ RESULTS AND DISCUSSION
Proteomic Screens To Identify Proteins with the Most
Constant Expression Levels
SDS lysates of six mouse organs and six human cell lines were
analyzed by label-free proteomics and in parallel by WB (Figure
1A−E and Table S1). Proteins exhibited a wide range of
variabilities in measured expression values in these diverse
systems. β-Actin and β-tubulin were in the middle of this
distribution (Figure 1A) and showed considerable variation as
well (Figure 1B−E). This was surprising because one would
have expected widely used loading controls to be among the
most stably expressed under different conditions. Instead, the
protein with the most constant expression levels in mouse
tissue and cultured human cells was an ubiquitously expressed
enzyme, the deglycase DJ-1 (Figure 1A−E). DJ-1 is encoded by
the PARK7 gene, mutations in which result in autosomal
recessive early-onset Parkinson disease 7.16 Remarkably, in light
of the nearly constant expression levels of this enzyme
documented here, this protein has been reported to be
deregulated in several cancer types (albeit often with low fold
changes), and as a consequence, it has frequently been
proposed as a biomarker candidate.17 Those low fold changes
Table 1. Summary of Previously Reported Values of the








brain24 0.050 ± 0.002 24.9 ± 0.9
eye24 0.071 ± 0.015 35.5 ± 7.7
heart24 0.038 ± 0.004 19.0 ± 1.9
liver24 0.060 ± 0.004 29.9 ± 2.2
lung24 0.043 ± 0.004 21.6 ± 2.1
ovary24 0.073 ± 0.015 36.5 ± 7.4
pituitary24 0.087 ± 0.006 43.6 ± 3.2
prostate24 0.033 ± 0.004 16.5 ± 2.0
thyroid24 0.053 ± 0.010 26.3 ± 5.1
muscle24 0.052 ± 0.010 26.2 ± 4.9
Human Cells and Organs
erythrocyte (fresh)25 0.062 ± 0.015 29.1 ± 10.5
colonic adenoma (FFPEa)26 0.069 ± 0.012 34.7 ± 5.9
colonic mucosa (FFPE)26 0.076 ± 0.027 38.8 ± 6.9
colonic adenocarcinoma (FFPE)26 0.077 ± 0.014 38.0 ± 13.5
hepatocyte (frozen)27 0.079 ± 0.010 39.5 ± 4.8
Human Cell Lines
HCT116 (colon cancer)25 0.071 ± 0.020 35.7 ± 10.2
K562 (leukemia)25 0.112 ± 0.004 56.1 ± 2.3
MCF7 (breast cancer)25 0.074 ± 0.002 37.4 ± 1.0
HepG2 (hepatoma)27 0.054 ± 0.002 27.0 ± 1.1
Caco2 (colon cancer) filter28 0.064 ± 0.006 32.5 ± 2.9
Caco2 plastic 3 days7 0.044 ± 0.006 22.4 ± 3.2
Caco2 plastic 2 weeks7 0.063 ± 0.004 31.8 ± 2.0
HeLa (cervical cancer)7 0.066 ± 0.010 33.6 ± 5.3
average 0.069 ± 0.017 34.6 ± 8.7
CV 0.25 0.25
aFFPE = formalin-fixed, paraffin-embedded.
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were often based on loading controls, which varied much more
than DJ-1 in our data sets.
In contrast to relative analyses, the total protein approach
(TPA)7,8 allows absolute quantitation based on normalized
intensities, thereby enabling the comparison of protein titers
among different archival data sets generated using different
peptide fractionation and mass spectrometric platforms. We
took advantage of this feature to compare DJ-1 concentrations
that were assessed in several previously published studies from
our laboratory. The levels of DJ-1 turned out to be similarly
stable within these data sets and between mouse and human
(Table 1 and Figure 1F). The protein constitutes 0.069 ±
0.017% of total cellular protein and occurs at a specific
concentration of 34.6 ± 8.7 pmol/mg of total protein. The
assessed DJ-1 titer values vary up to 2-fold among different
tissues and cell lines. Since DJ-1 is structurally conserved down
to prokaryotes,18 we asked whether its abundance is also
evolutionarily conserved. We prepared and analyzed whole-
tissue lysates of liver, heart, skeletal muscle, and oocytes from
the African frog Xenopus. TPA analysis revealed that the
concentrations of DJ-1 in the amphibian tissues and cells are
similar to those in mammals (Figure 1G and Figure 2C). This
finding suggests that the cellular concentration of DJ-1 is well-
maintained in diverse vertebrate species.
DJ-1 as a Loading Control in Western Blot Analysis
DJ-1 is a 20 kDa cytoplasmic protein, and therefore, it is easily
extractable as well as quantitatively transferable from
polyacrylamide gels to blotting membranes. Since small
proteins often dissociate from the blotting membrane,19 we
routinely fix proteins after the blotting procedure using diluted
glutaraldehyde over a short time.15,20,21 Blots with fixed
proteins can be stripped and reused for probing with different
antibodies. This procedure allows more accurate comparison of
different antigens on a single blot compared with several blots.
Care should be taken to avoid “overfixation”, which can affect
the antibody−antigen interaction. The expression levels of DJ-1
are 10−100-fold lower than those of β-actin, β-tubulin, and
GAPDH, and thus, problems with band saturation2 can be
avoided. Currently there are several different antibodies against
Figure 2. Performance of antibodies against DJ-1 (PARK7) protein in Western blot analysis. Antibodies from four different commercial sources
(indicated in parentheses) were tested on blots with whole-cell/tissue lysates of (A) cultured human cells, (B) mouse tissues and HeLa cells, and (C)
Xenopus laevis with mouse liver and human cells. Each of the antibodies used was declared by the manufacturer to stain human and mouse DJ-1, but
no information on the reactivities these antibodies against DJ-1 in X. laevis was available. (D) Total protein dilution series using whole tissue and cell
lysate. DJ-1 protein was visualized using antibodies B (Abcam). (E) Quantification of blots shown in (D). Each data point shows an average of two
independent measurements. The dashed lines show linear regression of the data in the range of 1−10 μg total protein.
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DJ-1 on the market. We tested the performance of four
different products that have been declared as reactive against
human and mouse DJ-1 on WB (Figure 2). All four antibodies
detected the antigen in human cell line samples in a uniform
way (Figure 2A). Two antibodies stained with a small variation
observed in the proteomics analyses of human and mouse
proteins (Figure 2B). These two antibodies were also useful for
detection of Xenopus DJ1 protein, but the intensity of staining
was weaker than for mouse and human controls (Figure 2C).
These results also highlight one key limitation of the WB
technique, namely, the properties of antibodies that often lack
desired specificity and affinity to the intended antigen.
Next we analyzed the intensity of antibody staining across a
series of sample dilutions (Figure 2D,E). This demonstrated
the utility of the anti-DJ1 antibodies (antibodies B) as a
quantification reference for sample loads from about 1 to about
20 μg of total protein. In this range, staining with β-actin
showed saturation, which disqualifies this protein from use as a
loading control. Western blotting is ubiquitously used and also
frequently demanded by reviewers for validation of proteomic
results. In view of the work presented here, it is our opinion
that WB can at best play only only a supportive role in the
evaluation of proteomic results. WB can provide unambiguous
results only when thoroughly tested antibodies are used, which
is rarely the case, as has been pointed out recently.6,22 In this
context, it should be considered whether another proteomic
analysis using a different proteomic platform would be a better
validation of proteomic data. For instance, this is readily
achieved by varying the sample preparation method, digestion
strategy, or peptide prefractionation or alternatively by
employing different mass spectrometers. It is worth emphasiz-
ing that the DJ-1 concentrations presented in this work were
calculated from several unrelated data sets that were generated
using various peptide fractionation schemes and different mass
spectrometers operating in distinct fragmentation modes (CID
or HCD). This stresses the advantages of robust comparison of
proteomics data, as is for instance possible with the TPA
approach.
■ CONCLUSIONS
Here we have established that the quantitative and unbiased
nature of MS-based proteomics can be used to advantage when
selecting proteins with stable expression patterns across diverse
biological systems. Specifically, we have identified a protein
marker for proteomic normalization in MS-based experiments
as well as in Western blot analyses in human, mouse, and
amphibian tissues and cells. The approach suggested here can
be used more widely to determine the suitability of proteins or
sets of proteins as loading and normalization controls for any
biological system. As we have shown here, historically selected
“household proteins” may not be the most suitable for this task
for technical and biological reasons. Conversely, expression data
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